# Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime

> **NCT02533960** · — · COMPLETED · sponsor: **University Hospital Heidelberg** · enrollment: 3832 (actual)

## Conditions studied

- Ischemic Stroke
- Intracerebral Hemorrhage
- Oral Anticoagulation
- Cardiovascular Diseases
- Vascular Diseases

## Interventions

- **OTHER:** not applicable (observational study)

## Key facts

- **NCT ID:** NCT02533960
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2021-01
- **Final completion:** 2022-06
- **Target enrollment:** 3832 (ACTUAL)
- **Last updated:** 2023-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533960, "Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02533960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*